Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry
Sign Up to like & getrecommendations! Published in 2022 at "Birth Defects Research"
DOI: 10.1002/bdr2.2091
Abstract: Belimumab is approved for active, autoantibodyâpositive systemic lupus erythematosus (SLE) and lupus nephritis, but limited data exist regarding its use in pregnancy. The Belimumab Pregnancy Registry (BPR, GSK Study BEL114256; NCT01532310) was created to evaluate… read more here.
Keywords: belimumab; pregnancy registry; belimumab pregnancy; pregnancy ... See more keywords
Results on exposure during pregnancy from a pregnancy registry for AS04-HPV-16/18 vaccine.
Sign Up to like & getrecommendations! Published in 2017 at "Vaccine"
DOI: 10.1016/j.vaccine.2017.08.042
Abstract: OBJECTIVE To assess pregnancy outcomes after exposure to AS04-HPV-16/18 vaccine (Cervarix, GSK, Belgium) prior to, or during pregnancy, as reported to a pregnancy registry. METHODS A pregnancy exposure registry was established to collect data in… read more here.
Keywords: as04 hpv; hpv vaccine; pregnancy; pregnancy registry ... See more keywords
Risk of Major Malformations in Infants After First-Trimester Exposure to Stimulants: Results From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of clinical psychopharmacology"
DOI: 10.1097/jcp.0000000000001702
Abstract: PURPOSE/BACKGROUND The prevalence of attention-deficit/hyperactivity disorder in adult females is 3% to 4%. Attention-deficit/hyperactivity disorder is highly comorbid with other psychiatric disorders such as mood, anxiety, and substance use disorders. For reproductive-aged women, the treatment… read more here.
Keywords: pregnancy registry; first trimester; pregnancy; infants first ... See more keywords